European PharmaNovo Nordisk Outsources Parkinson's Programs to AI Partner as Stock Surges 24.9%Salvado•Jun 9, 2026
European PharmaNovo Nordisk's 24.9% Rally Backs AI Partnership Model Over In-House BiologySalvado•May 31, 2026
